For example, a few proteins with important roles in human diseases such as beta-catenin (cancer), tau (Alzheimer's disease), and α-synuclein (Parkinson's) are targets of both GSK3 and O-GlcNAc (Yu et al., 2012; Ha et al., 2014). This evidence concerns the gene MAPT and Parkinsonism.